Expanded access to investigational drugs

被引：0
|
作者：
Douglas, Natalie [1 ]
机构：
[1] Idis
来源：
Genetic Engineering and Biotechnology News | 2010年 / 30卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R96 [药理学]; R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ; 100706 ;
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Expanded Access to Investigational Drugs
    Douglas, Natalie
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2010, 30 (02): : 38 - 39
  • [2] Expanded Access to Investigational Drugs REPLY
    Sarpatwari, Ameet
    Darrow, Jonathan J.
    Kesselheim, Aaron S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (15): : 1473 - 1474
  • [3] Expanded access to investigational drugs in psychiatry: A systematic review
    Vermeulen, Stefan F.
    Polak, Tobias B.
    Bunnik, Eline M.
    PSYCHIATRY RESEARCH, 2023, 329
  • [4] Expanded access program (EAP) to investigational drugs.
    Talarico, L
    Pazdur, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 519S - 519S
  • [5] Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs
    Darrow, Jonathan J.
    Sarpatwari, Ameet
    Avorn, Jerry
    Kesselheim, Aaron S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (03): : 279 - 286
  • [6] Navigating the Expanded Access Pathway to Investigational Drugs as an Academic Oncologist
    Lynch, Holly Fernandez
    Salam, Tasnim
    Gould, Patrick
    Bateman-House, Alison
    Kimberly, Laura
    JAMA NETWORK OPEN, 2023, 6 (02) : E230060
  • [7] Overview of FDA's Expanded Access Program for Investigational Drugs
    Jarow, Jonathan P.
    Lurie, Peter
    Ikenberry, Sarah Crowley
    Lemery, Steven
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (02) : 177 - 179
  • [8] Overview of FDA’s Expanded Access Program for Investigational Drugs
    Jonathan P. Jarow
    Peter Lurie
    Sarah Crowley Ikenberry
    Steven Lemery
    Therapeutic Innovation & Regulatory Science, 2017, 51 : 177 - 179
  • [9] Perspectives of Academic Oncologists About Offering Expanded Access to Investigational Drugs
    Gould, Patrick
    Salam, Tasnim
    Kimberly, Laura
    Bateman-House, Alison
    Lynch, Holly Fernandez
    JAMA NETWORK OPEN, 2022, 5 (11) : e2239766
  • [10] Access to Investigational Drugs: FDA Expanded Access Programs or "Right-to-Try" Legislation?
    Holbein, M. E. Blair
    Berglund, Jelena P.
    Weatherwax, Kevin
    Gerber, David E.
    Adamo, Joan E.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2015, 8 (05): : 526 - 532
12345